Business
Pharmagreen Biotech Inc. Announces that Registration Statement on Form S-1 has been Declared Effective - Pharmagreen is a Cannabis Company that is a producer of highest quality CBD Hemp Plantlets
Pharmagreen Biotech Inc. Announces that Registration Statement on Form S-1 has been Declared Effective - Pharmagreen is a Cannabis Company that is a producer of highest quality CBD Hemp Plantlets.
About this update from Pharmagreen Biotech Inc.
[{"type":"text","content":"\n\n\n\nPharmagreen Biotech Inc. Announces that Registration Statement on Form S-1 has been Declared Effective - Pharmagreen is a Cannabis Company that is a producer of highest quality CBD Hemp Plantlets\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPharmagreen Biotech Inc. Announces that Registration Statement on Form S-1 has been Declared Effective - Pharmagreen is a Cannabis Company that is a producer of highest quality CBD Hemp Plantlets\nPR Newswire\nCARSON CITY, NV, July 18, 2019\n\n\n\nCARSON CITY, NV, July 18, 2019 /PRNewswire/ - Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), announced today that the Securities and Exchange Commission (\"SEC\") has declared effective the Company's registration on Form S-1 (file 333-230413) relating to the sale from treasury of up to 20,000,000 shares of the Company's Class A common stock at an issue price of $2 per share, and the resale of 4,051,725 common stock  that have been issued to the Selling Stockholders named in this registration statement.\nPharmagreen will not receive any proceeds from the re-sale of the securities by the selling security stockholders.  Pharmagreen will receive the proceeds from the sale of the 20,000,000 shares issued out of treasury.\nThe registration statement may be accessed through the SEC's website at www.sec.gov. A copy of the prospectus relating to the offering may be obtained from Pharmagreen by writing Pharmagreen Biotech Inc., 2987 Blackbear Court, Coquitlam, BC, Canada, V3E 3A2 or emailing [email protected].\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.\nAbout Pharmagreen Biotech, Inc. and WFS Pharmagreen Inc.\nWFS Pharmagreen Inc. is a wholly owned Canadian based subsidiary of Pharmagreen Biotech, Inc., a publicly traded (OTC PINKS: PHBI) company.  WFS Pharmagreen Inc. is a cannabis ...